cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sutro Biopharma Inc
2 own
6 watching
Current Price
$4.5
$0.26
(6.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
294.4M
52-Week High
52-Week High
6.13000
52-Week Low
52-Week Low
2.00500
Average Volume
Average Volume
0.84M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization294.4M
icon52-Week High6.13000
icon52-Week Low2.00500
iconAverage Volume0.84M
iconDividend Yield--
iconP/E Ratio--
What does the Sutro Biopharma Inc do?
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company s product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Read More
How much money does Sutro Biopharma Inc make?
News & Events about Sutro Biopharma Inc.
Globe Newswire
9 months ago
- Sutro will receive $140 million upfront and is eligible to receive up to an additional $250 million in future milestone payments in exchange for the royalty, or revenue interest, in potential future sales of Vaxcytes products - - Transaction provides non-dilutive growth capital to Sutro for ...
Globe Newswire
12 months ago
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced expanded preclinical data for STRO-003, its ROR1 targeting ADC, ...
Globe Newswire
1 year ago
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Ticker Report
1 year ago
Sutro Biopharma (NASDAQ:STRO Get Rating) had its price objective lifted by research analysts at Piper Sandler from $16.00 to $18.00 in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage presently has an overweight rating on the stock. ...
Globe Newswire
1 year ago
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Frequently Asked Questions
Frequently Asked Questions
What is Sutro Biopharma Inc share price today?
plus_minus_icon
Can Indians buy Sutro Biopharma Inc shares?
plus_minus_icon
How can I buy Sutro Biopharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Sutro Biopharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sutro Biopharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Sutro Biopharma Inc?
plus_minus_icon
What is today’s market capitalisation of Sutro Biopharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sutro Biopharma Inc?
plus_minus_icon
What percentage is Sutro Biopharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sutro Biopharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.5
$0.26
(6.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00